-
Dihydroimidazothiazole Derivatives
申请人:Barba Oscar
公开号:US20090221645A1
公开(公告)日:2009-09-03
Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT
1A
agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.
式(I)的化合物或其药学上可接受的盐,除了去甲肾上腺素再摄取抑制外,还表现出5-HT1A受体激动作用,可选地还具有5-HT再摄取抑制作用,适用于肥胖症的治疗。
-
Sanchez, Joseph P.; Parcell, Robert F., Journal of Heterocyclic Chemistry, 1990, vol. 27, # 6, p. 1601 - 1607
作者:Sanchez, Joseph P.、Parcell, Robert F.
DOI:——
日期:——
-
Nakamura,H.; Goto,T., Heterocycles, 1978, vol. 10, p. 167 - 170
作者:Nakamura,H.、Goto,T.
DOI:——
日期:——
-
BERGMAN J.; BAECKVALL J. E., TETRAHEDRON <TETR-AB>, 1975, 31, NO 17, 2063-2073
作者:BERGMAN J.、 BAECKVALL J. E.
DOI:——
日期:——
-
NAKAMURA H.; GOTO T., HETEROCYCLES, 1978, 10, SPEC. ISSUE, 167-170
作者:NAKAMURA H.、 GOTO T.
DOI:——
日期:——